![]() |
市場調查報告書
商品編碼
1447137
到 2030 年椎間盤髓核置換術市場預測:按手術類型、材料、椎體位置、技術、最終用戶和地區進行的全球分析Spinal Laminoplasty Market Forecasts to 2030 - Global Analysis By Surgery Type, By Material (Polyetheretherketone Implants, Titanium Implants and Tantalum Implants), Vertebral Position, Technology, End User and By Geography |
根據 Stratistics MRC 的數據,2023 年全球椎板椎間盤髓核置換術市場規模為 59.8 億美元,預計在預測期內年複合成長率為 5.5%,到 2030 年將達到 87.1 億美元。
椎間盤髓核置換術是一種透過擴大脊椎來治療頸椎脊椎狹窄的外科手術。在層骨的一側創建鉸鏈併升高以允許脊髓和神經減壓。此方法可以維持脊髓的穩定性,同時緩解脊髓受壓引起的疼痛、麻木、無力等症狀。
根據 2021 年發表的一項研究,美國大約進行了 50 萬例腰椎手術。
脊椎狹窄盛行率上升
脊椎狹窄盛行率的上升是椎間盤髓核置換術市場的關鍵促進因素。脊椎狹窄的特徵是脊椎變窄,導致脊髓和神經受壓,引起疼痛、麻木和無力等症狀。脊椎椎間盤髓核置換術,擴大被採用作為脊椎狹窄患者的治療選擇。患者數量的增加正在推動椎間盤髓核置換術和相關醫療設備的需求,從而推動市場成長。
昂貴的治療費用
患者在接受照護時可能面臨經濟障礙,尤其是在醫療保險有限或自付費用較高的地區。此外,醫療保健提供者和設施可能在報銷和與付款人進行價格談判方面面臨挑戰,影響他們提供負擔得起的服務的能力。這些成本障礙阻礙了患者尋求或完成治療,並限制了椎間盤髓核置換術的整體市場潛力。
人們對微創手術的認知不斷增強
微創手術與傳統開放性手術相比具有優勢,包括減少術後疼痛、縮短住院時間和加快復原時間。隨著患者對這些益處的了解越來越多,對微創脊椎手術(包括椎間盤髓核置換術)的需求正在增加。這一趨勢正在推動手術技術和手術的創新,鼓勵醫療保健提供者採用微創方法並擴大其在椎間盤髓核置換術市場的產品範圍。
椎間盤髓核置換術相關的併發症
椎間盤髓核置換術相關的併發症對市場構成重大威脅。這些併發症,包括神經損傷、感染疾病和脊椎不穩定,可能導致術後併發症和患者不滿意。此外,再次手術和長期併發症的風險可能會阻止患者和醫療保健提供者選擇分層作為治療方案。此外,負面結果可能會損害該手術的聲譽,降低其採用率,並影響椎間盤髓核置換術市場的成長前景。
COVID-19 的爆發擾亂了擇期手術並減少了患者使用醫療機構的機會,從而影響了椎間盤髓核置換術市場。封鎖措施和疫情管理資源的重新分配導致非緊急脊椎手術被推遲。結果,提供椎間盤髓核置換術服務的醫療保健提供者的手術數量和收益減少。
開放椎間盤髓核置換術術領域預計將成為預測期內最大的領域
在預測期內,椎間盤髓核置換術市場預計將以開放椎間盤髓核置換術為主。這是因為開放式椎間盤髓核置換術是一種已使用多年的成熟手術技術。此外,與微創技術相比,開放椎間盤髓核置換術可以實現脊髓的可視化和減壓。此外,外科醫生對熟悉且經過驗證的手術方法的偏好也促進了脊椎手術中開放式椎間盤髓核置換術的持續需求。
預計 3D 列印產業在預測期內的年複合成長率最高。
預計 3D 列印領域在預測期內將在椎間盤髓核置換術市場中呈現最高成長率。這一成長是由 3D 列印技術的進步推動的,該技術能夠生產根據個體解剖結構量身定做的患者專用植入和手術器械。此外,3D 列印還具有提高手術精度、縮短製造時間和降低成本等優點。這些因素促使 3D 列印在椎間盤髓核置換術中得到越來越多的採用,並推動市場成長。
由於其先進的醫療基礎設施、脊椎疾病的高盛行率以及較早採用創新醫療技術,北美在椎間盤髓核置換術市場中佔據了最大的市場佔有率。此外,強力的報銷政策和有利的醫療保健法規支持脊椎手術在北美的普及。此外,領先的醫療設備公司和知名醫療機構的入駐進一步加強了該地區在椎板椎間盤髓核置換術市場的主導地位。
由於脊椎疾病盛行率的增加、醫療保健成本的上升以及先進醫療設施的普及,亞太地區的椎板椎間盤髓核置換術市場預計將快速成長。此外,醫療基礎設施的改善和脊椎健康意識的提高正在推動對椎間盤髓核置換術等手術干涉的需求。此外,該地區人口眾多、人口老化導致患者數量眾多,為亞太市場脊椎手術帶來了成長機會。
According to Stratistics MRC, the Global Spinal Laminoplasty Market is accounted for $5.98 billion in 2023 and is expected to reach $8.71 billion by 2030 growing at a CAGR of 5.5% during the forecast period. Spinal laminoplasty is a surgical procedure used to treat cervical spinal stenosis by enlarging the spinal canal. It involves creating a hinge on one side of the lamina bone and lifting it, allowing decompression of the spinal cord and nerves. This technique preserves spinal stability while providing relief from symptoms such as pain, numbness, and weakness caused by spinal cord compression.
According to a study published in 2021, approximately 500,000 lumbar spine surgeries were performed in the US.
Rising prevalence of spinal stenosis
The rising prevalence of spinal stenosis serves as a significant driver in the spinal laminoplasty market. Spinal stenosis, characterized by the narrowing of the spinal canal, leads to compression of the spinal cord and nerves, causing symptoms like pain, numbness, and weakness. Spinal laminoplasty, a surgical procedure aimed at alleviating spinal cord compression, is increasingly adopted as a treatment option for patients with spinal stenosis. This growing patient population drives demand for laminoplasty procedures and related medical devices, fostering market growth.
High cost of procedures
Patients may face financial barriers to accessing treatment, especially in regions with limited healthcare coverage or high out-of-pocket expenses. Additionally, healthcare providers and facilities may experience challenges in reimbursement and pricing negotiations with payers, impacting their ability to offer affordable services. This cost barrier can deter patients from seeking or completing treatment, thereby limiting the overall market potential for spinal laminoplasty procedures.
Growing awareness of minimally invasive surgeries
Minimally invasive techniques offer advantages such as reduced post-operative pain, shorter hospital stays, and quicker recovery times compared to traditional open surgeries. As patients become more informed about these benefits, there is a rising demand for minimally invasive spinal procedures, including laminoplasty. This trend drives innovation in surgical technologies and techniques, encouraging healthcare providers to adopt minimally invasive approaches and expand their offerings in the spinal laminoplasty market.
Complications associated with spinal laminoplasty
The complications associated with spinal laminoplasty pose a significant threat to the market. These complications, including nerve damage, infection, and instability of the spine, can lead to post-operative complications and patient dissatisfaction. Moreover, the risk of reoperation and long-term complications may deter both patients and healthcare providers from choosing laminoplasty as a treatment option. Additionally, negative outcomes can damage the reputation of the procedure and decrease its adoption rate, impacting the growth prospects of the spinal laminoplasty market.
The COVID-19 pandemic has impacted the spinal laminoplasty market by disrupting elective surgeries and reducing patient access to healthcare facilities. Lockdown measures and reallocation of resources towards managing the pandemic led to the postponement of non-urgent spinal procedures. This resulted in decreased procedural volumes and revenue for healthcare providers offering spinal laminoplasty services.
The open laminoplasty segment is expected to be the largest during the forecast period
Over the forecast period, the open laminoplasty segment is anticipated to dominate the spinal laminoplasty market. This is attributed to the long-standing use of and established surgical techniques associated with open laminoplasty procedures. Additionally, open laminoplasty allows for greater visualization and decompression of the spinal cord compared to minimally invasive techniques. Furthermore, the preference for familiar and proven surgical methods by surgeons contributes to the sustained demand for open laminoplasty procedures in spinal surgery.
The 3D printing segment is expected to have the highest CAGR during the forecast period
The 3D printing segment is projected to witness the highest growth rate in the spinal laminoplasty market during the forecast period. This growth is driven by advancements in 3D printing technology, enabling the production of patient-specific implants and surgical instruments tailored to individual anatomies. Additionally, 3D printing offers benefits such as improved surgical precision, faster production times, and reduced costs. These factors contribute to the increasing adoption of 3D printing in spinal laminoplasty procedures, fueling market growth.
North America is positioned to secure the largest market share in the spinal laminoplasty market due to the region's advanced healthcare infrastructure, high prevalence of spinal disorders, and early adoption of innovative medical technologies. Additionally, robust reimbursement policies and favorable healthcare regulations support the uptake of spinal procedures in North America. Moreover, the presence of leading medical device companies and renowned healthcare institutions further strengthens the region's dominance in the spinal laminoplasty market.
The Asia-Pacific region is poised for rapid growth in the spinal laminoplasty market owing to the increasing prevalence of spinal disorders, rising healthcare expenditures, and expanding access to advanced medical facilities. Additionally, improving healthcare infrastructure and growing awareness about spinal health drive demand for surgical interventions like laminoplasty. Moreover, the region's large population and aging demographics create a substantial patient pool, contributing to the growth opportunities for spinal procedures in the Asia-Pacific market.
Key players in the market
Some of the key players in Spinal Laminoplasty Market include Aesculap, Inc., Alphatec Holdings, Inc., Amedica Corporation, Captiva Spine, CoreLink, LLC, DePuy Synthes, Globus Medical Inc., Joimax GmbH, Medtronic plc, Nexxt Spine LLC, NuVasive, Inc., Orthofix Medical Inc., Osseus Fusion Systems, RTI Surgical Holdings, Inc., Spinal Elements, Inc., Spineart, Stryker Corporation, Ulrich Medical and Zimmer Biomet Holdings, Inc.
In October 2023, Johnson & Johnson MedTech announced that DePuy Synthes, The Orthopaedics Company of Johnson & Johnson, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its TriLEAP(TM) Lower Extremity Anatomic Plating System, a comprehensive yet modular, procedure-specific system designed to meet the complex needs of orthopaedic surgeons, doctors of podiatric medicine, and foot and ankle specialists. The TriLEAP(TM) System provides a diverse offering of contoured and conventional plates that can accommodate multiple screw diameters, and instruments that can be used during the reduction, internal fixation and fusion of bones and bone fragments.
In September 2023, Globus Medical, Inc., a leading musculoskeletal solutions company, today announced it has completed its previously announced merger with NuVasive, Inc. The combined company will provide surgeons and patients with one of the most comprehensive offerings of musculoskeletal procedural solutions and enabling technologies to impact the care continuum.
In December 2022, Captiva Spine announces an exclusive strategic partnership with REMEX Medical for Spine Navigation and Robotics, adding to their expanding product portfolio. For underserved hospitals and Ambulatory Surgery Centers (ASCs) throughout the U.S., this technology will serve as a platform to expand the company's products and services with enhanced enabling technology to support MIS technology. Specifically, Captiva Spine will be starting with their CapLOX Pedicle Screws, TowerLOX-EXT MIS Extended Tab Pedicle Screws, and TransFasten Posterior SI joint fusion system.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.